The estimated Net Worth of Denise M Oleary is at least $6.04 Миллион dollars as of 3 April 2020. Denise Oleary owns over 1,813 units of Medtronic Plc stock worth over $6,012,250 and over the last 11 years Denise sold MDT stock worth over $29,017.
Sign up
Denise Oleary MDT stock SEC Form 4 insiders trading
Denise has made over 11 trades of the Medtronic Plc stock since 2014, according to the Form 4 filled with the SEC. Most recently Denise exercised 1,813 units of MDT stock worth $80,008 on 3 April 2020.
The largest trade Denise's ever made was exercising 5,440 units of Medtronic Plc stock on 24 August 2015 worth over $310,080. On average, Denise trades about 657 units every 51 days since 2013. As of 3 April 2020 Denise still owns at least 66,544 units of Medtronic Plc stock.
You can see the complete history of Denise Oleary stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Medtronic Plc
Over the last 10 years, insiders at Medtronic Plc have traded over $102,147,437 worth of Medtronic Plc stock and bought 88,808 units worth $7,888,497 . The most active insiders traders include Randall J Hogan, Richard H Anderson и Scott C Donnelly. On average, Medtronic Plc executives and independent directors trade stock every 23 days with the average trade being worth of $1,897,982. The most recent stock trade was executed by Brett A. Wall on 2 August 2024, trading 5,311 units of MDT stock currently worth $479,849.
What does Medtronic Plc do?
Medtronic plc is an American medical device company. The companys operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.
What does Medtronic Plc's logo look like?
Complete history of Denise Oleary stock trades at American Airlines Inc и Medtronic Plc
Medtronic Plc executives and stock owners
Medtronic Plc executives and other stock owners filed with the SEC include:
-
Geoffrey Straub Martha,
Chairman & CEO -
Karen L. Parkhill,
EVP, CFO, IT & Enterprise Excellence -
Bradley E. Lerman,
Sr. VP, Gen. Counsel & Corp. Sec. -
Robert John White,
Exec. VP & Pres of Medical Surgical Portfolio -
Dr. Richard E. Kuntz M.D., M.Sc.,
Sr. VP and Chief Medical & Scientific Officer -
Ivan K. Fong,
Exec. VP, Gen. Counsel & Sec. -
Torod B. Neptune,
Sr. VP & Chief Communications Officer -
Ryan Weispfenning,
VP of Investor Relations -
Sean Lennon,
Chief Information Officer -
Jennifer M. Kirk,
Principal Accounting Officer, Global Controller & Chief Accounting Officer -
Mark Ploof,
Sr. VP of Global Operations and Bus. Services -
Randall J Hogan,
Director -
Shirley A Jackson,
Director -
Michael J Coyle,
EVP & Group Pres, Cardiac&Vasc -
Craig Arnold,
Director -
Bradley E Lerman,
SVP General Counsel & Corp Sec -
Robert C Pozen,
Director -
Hooman Hakami,
EVP & Group President Diabetes -
James T Lenehan,
Director -
Bryan C Hanson,
See Remarks -
Richard H Anderson,
Director -
Elizabeth G Nabel,
Director -
Karen L Parkhill,
EVP & Chief Financial Officer -
Gary Lee Ellis,
EVP & Chief Financial Officer -
Denise M Oleary,
Director -
Kendall J Powell,
Director -
Scott C Donnelly,
Director -
Gary Louis Corona,
Interim CFO -
Geoffrey Martha,
Chairman and CEO -
Gregory P Lewis,
Director -
John R Liddicoat,
EVP & President of Americas -
Andrea Jo Goldsmith,
Director -
Jennifer M Kirk,
Chief Accounting Officer -
Richard Kuntz,
SVP & Chief Medical & Science -
Preetha Reddy,
Director -
Michael O Leavitt,
Director -
Christopher J O Connell,
See Remarks -
Omar Ishrak,
Executive Chairman -
Robert John White,
EVP & Pres. Medical Surgical -
Carol A Surface,
EVP, Chief HR Officer -
Kevin E Lofton,
Director -
Sean Salmon,
EVP & President Cardiovascular -
Brett A. Wall,
EVP & Pres Neuroscience -
Ivan K Fong,
EVP GENERAL COUNSEL & SECR -
Hoedt Rob Ten,
EVP and Pres. Global Regions -
Gregory L Smith,
EVP Global Ops & Supply Chain -
Matthew R. Walter,
SVP, Chief HR Officer -
Lidia Fonseca,
Director -
Michael Marinaro,
EVP & President, Surgical OU